Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,140 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cause of death in clinical research: time for a reassessment?
Lauer MS, Blackstone EH, Young JB, Topol EJ. Lauer MS, et al. Among authors: topol ej. J Am Coll Cardiol. 1999 Sep;34(3):618-20. doi: 10.1016/s0735-1097(99)00250-8. J Am Coll Cardiol. 1999. PMID: 10483939 Review. No abstract available.
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
Brieger DB, Mak KH, White HD, Kleiman NS, Miller DP, Vahanian A, Ross AM, Califf RM, Topol EJ. Brieger DB, et al. Among authors: topol ej. Am J Cardiol. 1998 Feb 1;81(3):282-7. doi: 10.1016/s0002-9149(97)00909-0. Am J Cardiol. 1998. PMID: 9468068
A direct comparison of tirofiban and abciximab during percutaneous coronary revascularization and stent placement: rationale and design of the TARGET study.
Moliterno DJ, Topol EJ. Moliterno DJ, et al. Among authors: topol ej. Am Heart J. 2000 Nov;140(5):722-6. doi: 10.1067/mhj.2000.110094. Am Heart J. 2000. PMID: 11054616
Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade.
Cura FA, Kapadia SR, L'Allier PL, Schneider JP, Kreindel MS, Silver MJ, Yadav JS, Simpfendorfer CC, Raymond RR, Tuzcu EM, Franco I, Whitlow PL, Topol EJ, Ellis SG. Cura FA, et al. Among authors: topol ej. Am J Cardiol. 2000 Oct 1;86(7):780-2, A9. doi: 10.1016/s0002-9149(00)01081-x. Am J Cardiol. 2000. PMID: 11018201
Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators.
Bhatt DL, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Bhatt DL, et al. Among authors: topol ej. Am Heart J. 2000 Jul;140(1):67-73. doi: 10.1067/mhj.2000.108239. Am Heart J. 2000. PMID: 10874265 Clinical Trial.
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.
Topol EJ, Mark DB, Lincoff AM, Cohen E, Burton J, Kleiman N, Talley D, Sapp S, Booth J, Cabot CF, Anderson KM, Califf RM. Topol EJ, et al. Lancet. 1999 Dec 11;354(9195):2019-24. doi: 10.1016/s0140-6736(99)10018-7. Lancet. 1999. PMID: 10636365 Clinical Trial.
Heparin-induced thrombocytopenia.
Brieger DB, Mak KH, Kottke-Marchant K, Topol EJ. Brieger DB, et al. Among authors: topol ej. J Am Coll Cardiol. 1998 Jun;31(7):1449-59. doi: 10.1016/s0735-1097(98)00134-x. J Am Coll Cardiol. 1998. PMID: 9626819 Review.
Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group.
Topol EJ, Califf RM, Van de Werf F, Simoons M, Hampton J, Lee KL, White H, Simes J, Armstrong PW. Topol EJ, et al. Circulation. 1997 Feb 18;95(4):1072-82. doi: 10.1161/01.cir.95.4.1072. Circulation. 1997. PMID: 9054772 Review. No abstract available.
Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy.
Sane DC, Damaraju LV, Topol EJ, Cabot CF, Mascelli MA, Harrington RA, Simoons ML, Califf RM. Sane DC, et al. Among authors: topol ej. J Am Coll Cardiol. 2000 Jul;36(1):75-83. doi: 10.1016/s0735-1097(00)00688-4. J Am Coll Cardiol. 2000. PMID: 10898416 Clinical Trial.
1,140 results
Jump to page